ENVVENO MEDICAL CORP (NVNO)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$11.44+3.06%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · NVNO
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| Revenues | — | — | — | — | — | — | — | 0.0 | 0.2 |
| Cost of Revenues | — | — | — | — | — | — | — | — | 0.4 |
| Gross Profit | — | — | — | — | — | — | — | — | 0.2 |
| Operating Expenses & Income | |||||||||
| Selling, General & Admin | 8.0 | 10.9 | 11.6 | 11.7 | 15.0 | 11.2 | 4.9 | 4.9 | 6.5 |
| R&D Expenses | 8.7 | 10.0 | 12.2 | 13.6 | 9.9 | 5.7 | 4.3 | 2.2 | 1.2 |
| Operating Income | (16.8) | (20.9) | (23.8) | (25.2) | (24.9) | (16.9) | (9.1) | (7.7) | (7.9) |
| Earnings from Continuing Operations | |||||||||
| Other Non-Operating Income / Expenses | 1.0 | 1.4 | 2.0 | 1.7 | 0.3 | 0.4 | (0.0) | (0.0) | 5.2 |
| Asset Writedown | — | — | — | — | — | — | — | 0.6 | 0.3 |
| EBT, Incl. Unusual Items | — | (19.5) | — | — | — | — | — | — | — |
| Net Income | |||||||||
| Net Income | (15.7) | (19.5) | (21.8) | (23.5) | (24.7) | (16.5) | (9.1) | (7.6) | (13.0) |
| Per Share | |||||||||
| Basic EPS | (23.43) | (33.06) | (1.27) | (1.91) | (2.20) | (1.90) | — | — | — |
| Diluted EPS | (23.43) | (33.06) | (1.27) | (1.91) | (2.20) | — | — | — | — |
| Basic Weighted Avg Shares | 0.7 | 0.6 | 17.1 | 12.3 | 11.2 | 8.7 | — | — | — |
| Diluted Weighted Avg Shares | 0.7 | 0.6 | 17.1 | 12.3 | 11.2 | — | — | — | — |
| Supplemental | |||||||||
| EBITDA | — | (20.8) | (23.6) | (25.0) | (24.7) | (16.7) | (9.0) | (7.6) | (7.7) |
| EBIT | (16.8) | (20.9) | (23.8) | (25.2) | (24.9) | (16.9) | (9.1) | (7.7) | (7.9) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.